MiMedx Group (MDXG) Getting Somewhat Favorable News Coverage, Study Finds

Headlines about MiMedx Group (NASDAQ:MDXG) have been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. MiMedx Group earned a media sentiment score of 0.24 on Accern’s scale. Accern also gave media headlines about the medical equipment provider an impact score of 44.0147018215591 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Here are some of the media headlines that may have impacted Accern’s analysis:

MiMedx Group (MDXG) opened at $11.45 on Thursday. The firm has a market capitalization of $1,288.01, a P/E ratio of 55.24, a price-to-earnings-growth ratio of 2.76 and a beta of 0.87. MiMedx Group has a 12-month low of $7.64 and a 12-month high of $17.47.

MiMedx Group (NASDAQ:MDXG) last announced its quarterly earnings results on Thursday, October 26th. The medical equipment provider reported $0.08 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.08. The firm had revenue of $84.60 million for the quarter, compared to the consensus estimate of $84.60 million. MiMedx Group had a return on equity of 17.49% and a net margin of 11.64%. The business’s revenue was up 31.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.06 earnings per share. equities research analysts anticipate that MiMedx Group will post 0.24 earnings per share for the current fiscal year.

MiMedx Group declared that its Board of Directors has authorized a share repurchase program on Monday, October 9th that allows the company to buyback $10.00 million in outstanding shares. This buyback authorization allows the medical equipment provider to reacquire shares of its stock through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.

Several research firms recently issued reports on MDXG. Needham & Company LLC upped their target price on MiMedx Group from $20.00 to $21.00 and gave the stock a “strong-buy” rating in a report on Tuesday, September 5th. Piper Jaffray Companies reiterated a “buy” rating and set a $18.00 target price on shares of MiMedx Group in a report on Sunday, August 20th. BidaskClub upgraded MiMedx Group from a “hold” rating to a “buy” rating in a report on Thursday, August 10th. Finally, Zacks Investment Research downgraded MiMedx Group from a “hold” rating to a “sell” rating in a research report on Wednesday, October 4th. Three investment analysts have rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the stock. MiMedx Group has an average rating of “Hold” and a consensus price target of $15.40.

ILLEGAL ACTIVITY NOTICE: “MiMedx Group (MDXG) Getting Somewhat Favorable News Coverage, Study Finds” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US & international copyright legislation. The legal version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3078951/mimedx-group-mdxg-getting-somewhat-favorable-news-coverage-study-finds.html.

About MiMedx Group

MiMedx Group, Inc is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone. The Company’s Regenerative Biomaterials segment includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories.

Insider Buying and Selling by Quarter for MiMedx Group (NASDAQ:MDXG)

Receive News & Ratings for MiMedx Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiMedx Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.